Regulatory & Legal

In post-acute care, is training enough? A new digital platform aims to verify caregiver skills at the bedside, tackling both compliance and care quality.

Domestic manufacturing, massive power demands from AI and EVs, and a skilled labor shortage are converging to define a pivotal year for American industry.

With a $12M boost from a16z, Pryzm's AI is tackling the Pentagon's $900B procurement problem. Can software fix bureaucracy and secure America's edge?

Cohere Health's new Policy Studio uses AI to digitize archaic medical policies, promising to cut costs, ease provider burden, and meet new regulations.

A Texas vehicle maker is deploying its Bitcoin into regulated DeFi. Is this a risky gamble or the new blueprint for corporate finance innovation?

Secure identity firm CLEAR lands a major CMS contract to overhaul Medicare.gov's login system, signaling a strategic push into the government sector.

A family-owned store's record safe sales reveal a story of niche retail, tax incentives, and a parent company's ambitious 'patriotic lifestyle' gamble.

A famed NYC pub's arrival signals a new era for Atlanta's downtown, as the massive Centennial Yards project races to redefine the city for a global stage.

As 4G fades and full 5G remains costly, a new technology offers a balanced solution, making advanced, secure connectivity a reality for every driver.

Law firm Gunderson Dettmer's major partner expansion signals confidence not in the whole market, but in the AI-driven, high-value core of the venture economy.

A new narcolepsy drug could finally offer patients what they've been missing: a single nightly dose with low sodium, transforming lives and the market.

Century Therapeutics adds M&A and investment heavyweights to its board, a strategic move to navigate the clinical gauntlet with its iPSC-derived diabetes cure.

Celldex is launching a pivotal Phase 3 trial for a drug that could be the first advanced therapy for two debilitating and untreated chronic hive conditions.

A mandatory disclosure from a Boston investment giant reveals its position in a $1.4B merger. What does it signal for the future of the auto industry?

As AI systems grow more powerful, they also become vulnerable. A new German research initiative aims to build the tools to detect AI manipulation.

A new grant funds maternal health navigators in Mississippi, building a human infrastructure to combat one of the nation's worst maternal health crises.

A fierce bidding war for Avadel Pharmaceuticals reveals the high value of its key drug, as filings from giants like State Street highlight M&A transparency.

Eli Lilly's groundbreaking leukemia drug data signals a major market shift, promising better patient outcomes and fortifying its long-term growth strategy.

Target RWE's strategic hire of NoviSci co-founder Alan Brookhart signals a major push to master regulatory-grade real-world evidence. What does this mean?

A new patent for its lead cancer drug in Japan is more than a legal win; it's a strategic move to secure a future market into the 2040s.